Molecular Targeted α-Particle Therapy for Oncologic Applications
- 1 August 2014
- journal article
- review article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 203 (2) , 253-260
Abstract
OBJECTIVE. A significant challenge facing traditional cancer therapies is their propensity to significantly harm normal tissue. The recent clinical success of targeting therapies by attaching them ...Keywords
This publication has 87 references indexed in Scilit:
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate CancerNew England Journal of Medicine, 2013
- Experimental α-particle radioimmunotherapy of breast cancer using 227Th-labeled p-benzyl-DOTA-trastuzumabEJNMMI Research, 2011
- Radioimmunotherapy of Breast Cancer Metastases with α-Particle Emitter 225Ac: Comparing Efficacy with 213Bi and 90YCancer Research, 2009
- Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesisProceedings of the National Academy of Sciences, 2009
- Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applicationsAdvanced Drug Delivery Reviews, 2008
- A pilot study: 131I-Antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boostNeuro-Oncology, 2008
- Targeted α-particle radiotherapy with 211At-labeled monoclonal antibodiesNuclear Medicine and Biology, 2007
- Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspectsNuclear Medicine and Biology, 2007
- Engineered antibody fragments and the rise of single domainsNature Biotechnology, 2005
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987